you can find ideas everywhere, and i'm really always, and this is the theme of "mad money kwem" agios pharmaceuticals could be an interesting speck investment and you can read the article before thinking about buying it. there's plenty of "mad money" ahead including the breaches which companies are taking it on the chin and which could be in high demand. i've got the scoop and then from the growth in china to the concerns in europe, in this overseas situation there will be winners and losers, i'll point out the weak spots and alert you to the one set of stocks that are poised to triumph in the turmoil, but first amazon and apple and the charts say one more rally and the other could be in danger and find out which one is which. stick with cramer. they're custom made trains. you can't get any better than that. siemens trains are not your grandparent's technology. they're something that's gonna change the cities we live in today. i find it so fascinating how many people ride this and go to work every single day. i'm one of the lucky guys. i get to play with trains. people say, "wow, we s

massive pop for agios, the cancer drug. >> kudos to jim cramer who a week and a half was positive on this. you can't chase it here. it goes to show you the strength that some of the bio space they have. alex celgene. >> a pop-up 2% getting bumped to a bye rating. >> that was mr. mom on whatever it takes. altria, a story about their investments. it was dying 20 years ago. they own 20% of sad miller. i own it. i stay long. >> what are you guys talking about? there is like an inside joke. >> you ask how many votes are going to put in? >> now everybody knows. we are all on the same page. >>> drop for fives are down 1%. that will significantly delay the development of it sickle cell drug. >> it is a slight drop. i still like this name. when you look at it on a forward pfrmt "p." it is trading closer to that. >> michael keaton, up 7%, b.k. >> obviously, a big regis favorite. he is a winner again here. up 7% on good news. usually, up 7%. he takes the profits. i wouldn't here. i think this is a blast for .335. nike popping to a record high on a solid earnings beat. what it might mean for the

check out shares of agios. company's ceo saying the drug has the potential to make a big difference for blood cancer patients. now over to washington, d.c. with the news alert. >>> new information on a bizarre and gruesome situation that happened late last night in moore, oklahoma at the von foods processing plant. a 30-year-old alten nolan was recently fired. he went in the front door of the processing plant there in moore, oklahoma with a knife, attacked a person, an employee right in the entry way there and beheaded her and then proceeded to attack a second employee at the firm. at that point the coo of vaughan foods who is a reserve deputy emerged from his office with a gun and shot alten nolan. take a listen here to the police news conference earlier today for more details on this bizarre case. >> after conducting interviews with co-workers of nolan information was obtained that he recently started trying to convert some of his co workers to the muslim religion. due to the manner of death and initial state

we have a tweet who asks me to ring the register at $60 for agio. here is how i feel about it.ught it it seems like a lot of people did then i think you should sell some. i got in because of a new york article by dr. jerry who is the foremost guy when it comes to this analysis. i stick by it. it is not done going higher. and those of you who laughed and criticized me on twitter for saying good things about it why don't you rethink yourself and start focusing? stay with cramer. if you ware a denture, take the simple test. press your tongue against it like this. it moves unlike natural teeth. do you feel it? it can happen with every denture. introducing new fixodent plus true feel. it helps keep dentures firmly in place. with a smooth formula, free of flavors and colorants. so you get a closer feeling to natural teeth. new fixodent plus true feel. fixodent. and forget it. "hello. you can go ahead and "have a nice flight."re." ♪ music plays ♪ music plays traveling can feel like one big mystery. you're never quite sure what is coming your way. but when you've got an entire company

. ♪ mattress discounters >>> agio.jerome grouping, one of the great doctors i had the privilege of seeing was saying absolutely this may be the first big break in the nway to kelill cancer. they are going to have stage 1 success. celgene has the right to market these products. i've got to tell you, this is it. >> people interested can read the latest article. this is what you're talking about. >> just go look at the article. when i did the piece, highlighting this, people told me i didn't know what i was talking about. it's jerry groupman. >> it's still very early. >> that's the thing. why would you do that? present it in november? why present stage one? you shouldn't do that yet unless it's big. >> let's get breaking news and go to rick santelli. >> the mid month look was 84.6. it is now the final september read. if it moved the needle 84.6. that isn't a bad level to put it in some form of historical context. the next best number if you were to comp it would be 85.1. that was july of last year. that was the highest re

government bailed out agio, the long time ceo is suing for damages. the trial begins today.ary thompson is in washington where the trial is taking place. she's got more for us, including who's going to be there. mary? >> reporter: good morning, sara. opening arguments under way as we speak in what is -- what will be a six-week trial. boyce, representing greenberg's firm is saying, there is nothing more of critical to our rule in law than power and discretion of government officials, that power and discretion must be used within the established rule of law. if not, it has no beginning and no end. arguing that the government violated aig and its shareholders' fifth amendment rights during $182 billion takeover, claiming it unlawfully demanded equity in aig in return for loans and demand punitive interest rates on loans, interest rates that it didn't charge other firms that provided aid to during the crisis. starr international is greenberg's investment firm, the largest shareholder in aig. the lead plaintiff in this class-action lawsuit. this, opening arguments but during the